Market Closed -
OTC Markets
11:55:45 14/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.00025
USD
|
+25.00%
|
|
0.00%
|
-25.00%
|
Fiscal Period: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
13.7
|
15.75
|
6.069
|
7.41
|
4.276
|
2.079
|
Enterprise Value (EV)
1 |
13.71
|
15.74
|
6.091
|
7.518
|
4.205
|
2.473
|
P/E ratio
|
-8.05
x
|
-16.3
x
|
-6.25
x
|
-6.81
x
|
-2.15
x
|
-0.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-30,54,288
x
|
EV / FCF
|
-30.2
x
|
-83.9
x
|
-10.6
x
|
-35.3
x
|
-35.2
x
|
-4.41
x
|
FCF Yield
|
-3.31%
|
-1.19%
|
-9.43%
|
-2.84%
|
-2.84%
|
-22.7%
|
Price to Book
|
-8.96
x
|
-7.85
x
|
-3.38
x
|
-3.02
x
|
-1.86
x
|
-0.81
x
|
Nbr of stocks (in thousands)
|
2,49,148
|
2,64,649
|
3,46,773
|
4,46,386
|
6,47,886
|
20,78,709
|
Reference price
2 |
0.0550
|
0.0595
|
0.0175
|
0.0166
|
0.006600
|
0.001000
|
Announcement Date
|
12/10/18
|
30/09/19
|
20/10/20
|
12/10/21
|
14/10/22
|
13/10/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-0.8097
|
EBIT
1 |
-1.003
|
-0.8757
|
-0.7475
|
-0.8218
|
-1.134
|
-0.8109
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-1.642
|
-0.9292
|
-0.8056
|
-0.9247
|
-1.652
|
-0.9354
|
Net income
1 |
-1.642
|
-0.9292
|
-0.8056
|
-0.9247
|
-1.652
|
-0.9354
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.006836
|
-0.003648
|
-0.002800
|
-0.002438
|
-0.003072
|
-0.001315
|
Free Cash Flow
1 |
-0.4537
|
-0.1877
|
-0.5746
|
-0.2131
|
-0.1196
|
-0.5607
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/10/18
|
30/09/19
|
20/10/20
|
12/10/21
|
14/10/22
|
13/10/23
|
Fiscal Period: Giugno |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.01
|
-
|
0.02
|
0.11
|
-
|
0.39
|
Net Cash position
1 |
-
|
0.01
|
-
|
-
|
0.07
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.4871
x
|
Free Cash Flow
1 |
-0.45
|
-0.19
|
-0.57
|
-0.21
|
-0.12
|
-0.56
|
ROE (net income / shareholders' equity)
|
114%
|
54.1%
|
42.8%
|
44.9%
|
73.4%
|
37.5%
|
ROA (Net income/ Total Assets)
|
-864%
|
-2,723%
|
-719%
|
-627%
|
-627%
|
-499%
|
Assets
1 |
0.19
|
0.0341
|
0.1121
|
0.1474
|
0.2634
|
0.1873
|
Book Value Per Share
2 |
-0.0100
|
-0.0100
|
-0.0100
|
-0.0100
|
-0
|
-0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/10/18
|
30/09/19
|
20/10/20
|
12/10/21
|
14/10/22
|
13/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -25.00% | 8L | | -28.87% | 147.83Cr | | +29.98% | 14Cr | | +136.45% | 13Cr | | +14.37% | 7.9Cr |
Biometric Products
|